| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/04/2011 | CN101429254B Bletilla striata polysaccharide, preparation method and new uses thereof |
| 05/04/2011 | CN101411375B Cold tea for preventing and treating coprostasis type sub-health and preparation method thereof |
| 05/04/2011 | CN101401815B Cuttlebone polysaccharide extract CBP-S and uses thereof |
| 05/04/2011 | CN101384262B Use of pyrimidinedione derivative for preventing or treating hepatitis c |
| 05/04/2011 | CN101380408B Traditional Chinese medicine for treating infant persisting diarrhea |
| 05/04/2011 | CN101323850B Lactobacillus helveticus microcapsule, preparation and use thereof |
| 05/04/2011 | CN101288716B Chinese medicinal composition for treating toothache and its preparation method |
| 05/04/2011 | CN101284072B Externally used Chinese medicine for curing the dentalgia |
| 05/04/2011 | CN101279041B Chinese medicinal composition for curing ulcer of upper digestive tract |
| 05/04/2011 | CN101278991B Method for testing effective ingredients of Gegen Qinlian medicine |
| 05/04/2011 | CN101223994B Mouth refreshing product for eliminating halitosis |
| 05/04/2011 | CN101215544B Inflammation-inhibiting compounds |
| 05/04/2011 | CN101194950B Powder medicine medicament for treating children's stomatitis |
| 05/04/2011 | CN101161248B Novel anti-hepatitis B virus medicine preparing method |
| 05/04/2011 | CN101126057B Kudzu root health care medicinal liquor |
| 05/04/2011 | CN101115839B Method for inhibiting fibrogenesis by an rhdecorin-fc fusion protein |
| 05/04/2011 | CN101095759B Medicine that is coated on the navel for treating constipation |
| 05/04/2011 | CN101062097B Compound for improving and treating fatty liver |
| 05/04/2011 | CN101040657B Expanded pelleted feed for black eel fishes without pollution |
| 05/04/2011 | CN101028374B Chinese-medicinal preparation for treating liver diseases and its preparation method and use |
| 05/04/2011 | CN101014580B Morpholine compound |
| 05/04/2011 | CN101011483B Chinese medicinal formulation for treating children's digestive system disease and its preparation method |
| 05/03/2011 | US7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/03/2011 | US7935784 Immunoglobulin fusion which targets extracellullar domain of human estrogen receptor for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 05/03/2011 | US7935675 Immunostimulatory nucleic acid molecules |
| 05/03/2011 | US7935343 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders |
| 05/03/2011 | CA2539029C Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein |
| 05/03/2011 | CA2484340C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/03/2011 | CA2467517C Substituted benzoxazoles and analogues as estrogenic agents |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2443632C Timed pulse release composition |
| 05/03/2011 | CA2440438C Heterocyclic compounds |
| 05/03/2011 | CA2440091C Prodrugs of anticancer agents employing substituted aromatic acids |
| 05/03/2011 | CA2421109C Efficient method for producing compositions enriched in anthocyanins |
| 05/03/2011 | CA2341503C Probiotic, lactic acid-producing bacteria and uses thereof |
| 05/03/2011 | CA2321700C Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| 05/03/2011 | CA2283680C Calcium phosphopeptide complexes |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011049155A1 Process for production of quinuclidine compounds |
| 04/28/2011 | WO2011049053A1 Intestinal mucosa-inherent myeloid cells inhibiting t cell activation and utilization of same |
| 04/28/2011 | WO2011049042A1 Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient |
| 04/28/2011 | WO2011048936A1 Aminothiazole derivative |
| 04/28/2011 | WO2011048766A1 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases |
| 04/28/2011 | WO2011048125A1 Oral delivery of therapeutically effective lna oligonucleotides |
| 04/28/2011 | WO2011047481A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/28/2011 | WO2011026966A3 Method of treating eosinophilic esophagitis |
| 04/28/2011 | WO2010144498A9 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate |
| 04/28/2011 | WO2010141592A3 Chemical fragment screening and assembly utilizing common chemistry for nmr probe introduction and fragment linkage |
| 04/28/2011 | WO2010135736A3 Application and uses of prg4 and therapeutic modulation thereof |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/28/2011 | US20110098365 Salt product |
| 04/28/2011 | US20110098361 Composition to enhance the bioavailability of curcumin |
| 04/28/2011 | US20110098347 Phosphorous binder for treatment of kidney disease |
| 04/28/2011 | US20110098330 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 04/28/2011 | US20110098328 Heterocyclic derivatives as modulators of ion channels |
| 04/28/2011 | US20110098319 Fatty acid derivatives for oral administration endowed with high palatability |
| 04/28/2011 | US20110098311 Compositions for treatment of cystic fibrosis and other chronic diseases |
| 04/28/2011 | US20110098308 Azaindazole compounds and methods of use |
| 04/28/2011 | US20110098306 Uses of tetrahydrobiopterin, sepiapterin and derivatives thereof |
| 04/28/2011 | US20110098304 Small molecule inhibitors of PARP activity |
| 04/28/2011 | US20110098302 Cyclic diaryl ether compounds as antagonists of prostaglandin d2 receptors |
| 04/28/2011 | US20110098299 Spirolactam derivatives and uses of same |
| 04/28/2011 | US20110098288 Sulfonamides as zap-70 inhibitors |
| 04/28/2011 | US20110098269 Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands |
| 04/28/2011 | US20110098257 Derivatives of 4- or 5-aminosalicylic acid |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/28/2011 | US20110098245 Agent for preventing or ameliorating obesity |
| 04/28/2011 | US20110098226 Small molecular weight TNF receptor multimeric molecule |
| 04/28/2011 | US20110098223 Use of the pat nanopeptide in the treatment of autoimmune diseases |
| 04/28/2011 | US20110098219 System for Curing Hepatic Cancer with Leptin |
| 04/28/2011 | US20110098217 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| 04/28/2011 | US20110098213 Novel peptides for use in the treatment of obesity |
| 04/28/2011 | US20110097405 Estradiol-containing drug delivery system |
| 04/28/2011 | US20110097401 Methods for treating gastrointestinal disorders |
| 04/28/2011 | US20110097394 Type a gelatin capsule containing pufa in free acid form |
| 04/28/2011 | US20110097390 Ultra-Small RNAs as Toll-Like Receptor-3 Antagonists |
| 04/28/2011 | US20110097367 Monolithic in-situ cross-linked alginate implants |
| 04/28/2011 | US20110097344 Compositions, Methods for Treatment, and Diagnoses of Autoimmunity-Related Disorders and Methods for Making Such Compositions |
| 04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
| 04/28/2011 | US20110097284 Use and methods for preventing and/or treating oral malodour |
| 04/28/2011 | US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease |
| 04/28/2011 | DE202010016398U1 Verbesserungen bei pharmazeutischen Zusammensetzungen und bezüglich pharmazeutischer Zusammensetzungen With respect to improvements in pharmaceutical compositions and pharmaceutical compositions |
| 04/28/2011 | CA2778279A1 Method and kit for gastro-intestinal cleansing |
| 04/28/2011 | CA2777758A1 Peptidic glp-2 agonists |
| 04/27/2011 | EP2314624A2 Human antibody molecules for IL-13 |
| 04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |
| 04/27/2011 | EP2314317A2 Anti-glypican 3 antibody |
| 04/27/2011 | EP2314315A1 A blocking monoclonal antibody to the human alpha1 I-domain of VLA-1, and its use for the treatment of inflammatory disorders |
| 04/27/2011 | EP2314307A1 Enzyme-containing composition, process of producing said composition and its use |
| 04/27/2011 | EP2314301A2 Sensitization of chemotherapeutic agent-resistant neoplastic cells with various viruses |
| 04/27/2011 | EP2313393A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 04/27/2011 | EP2313392A1 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 04/27/2011 | EP2313099A2 Use of rifalazil to treat colonic disorders |
| 04/27/2011 | EP2313093A2 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 04/27/2011 | EP1976520B1 Kit comprising an osmotic laxative and a stimulant laxative for preparing the colon for virtual colonoscopy |
| 04/27/2011 | EP1439175B1 Pyrimidine compound and medicinal composition thereof |
| 04/27/2011 | EP1303541B1 Compositions containing metronidazole |
| 04/27/2011 | EP1257292B1 Use of il-18 inhibitors |
| 04/27/2011 | EP1177796B1 Medicament for prevention or therapeutic treatment of liver disease |